Review
doi: 10.1016/j.beha.2007.02.004.
Chemoimmunotherapy of chronic lymphocytic leukemia
Affiliations
- PMID: 17707835
- DOI: 10.1016/j.beha.2007.02.004
Item in Clipboard
Review
Chemoimmunotherapy of chronic lymphocytic leukemia
Best Pract Res Clin Haematol.
2007 Sep.
Abstract
The past two decades have seen a major paradigm shift in the therapy of chronic lymphocytic leukemia (CLL), with the treatment goal shifting from symptom palliation to the attainment of maximal disease control using the most effective frontline regimens available, thus prolonging survival and possibly leading to cure. The most potent therapeutic regimens developed to date include the chemoimmunotherapy combinations incorporating purine analogs and monoclonal antibodies. We review the evolution of modern chemoimmunotherapy for CLL, and discuss current research directions for further refining the potency of these regimens.
Similar articles
-
Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.Curr Hematol Rep. 2004 Jan;3(1):47-53. Curr Hematol Rep. 2004. PMID: 14695850 Review.
-
Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.Transfus Apher Sci. 2005 Feb;32(1):33-44. doi: 10.1016/j.transci.2004.10.004. Transfus Apher Sci. 2005. PMID: 15737872 Review.
-
Monoclonal antibody combinations in CLL: evolving strategies.Best Pract Res Clin Haematol. 2006;19(4):781-93. doi: 10.1016/j.beha.2006.06.005. Best Pract Res Clin Haematol. 2006. PMID: 16997183 Review.
-
Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.Leuk Res. 2004 May;28(5):429-42. doi: 10.1016/j.leukres.2003.08.017. Leuk Res. 2004. PMID: 15068894 Review.
-
[Current concepts in chronic lymphocytic leukemia. Better chances for young patients].MMW Fortschr Med. 2003 Jul 10;145(27-28):46-9. MMW Fortschr Med. 2003. PMID: 14587189 Review. German. No abstract available.
Cited by
-
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.Cancer Immunol Immunother. 2011 Jan;60(1):75-85. doi: 10.1007/s00262-010-0920-3. Epub 2010 Sep 21. Cancer Immunol Immunother. 2011. PMID: 20857100 Free PMC article.
-
Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms.Mol Med Rep. 2015 Nov;12(5):7374-88. doi: 10.3892/mmr.2015.4364. Epub 2015 Sep 25. Mol Med Rep. 2015. PMID: 26458979 Free PMC article.
-
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.Nat Cell Biol. 2012 Feb 19;14(3):276-86. doi: 10.1038/ncb2432. Nat Cell Biol. 2012. PMID: 22344033 Free PMC article.
-
Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia.Cancer. 2010 May 1;116(9):2180-7. doi: 10.1002/cncr.25028. Cancer. 2010. PMID: 20187101 Free PMC article. Clinical Trial.
-
Regulation of B-cell entry into the cell cycle.Immunol Rev. 2008 Aug;224:183-200. doi: 10.1111/j.1600-065X.2008.00652.x. Immunol Rev. 2008. PMID: 18759927 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
